Multiple drug

Multiple drug Reactions 1680, p235 - 2 Dec 2017 causality score was 1 (possibly treatment related). CAse 8: A 61-year-old man, who was diagnosed with HCV- infection and cirrhosis received treatment with sofosbuvir and ribavirin. After 1.9 weeks of the treatment, he developed Various toxicities: 16 case reports * hyperbilirubinaemia. Later, he was hospitalised due to In a observational cohort study, 16 patients (5 women and – portosystemic encephalopathy. Her hyperbilirubinaemia 11 men) aged 40 79 years were described, who developed improved after ribavirin dosage reduction and portosystemic various toxicities during treatment with sofosbuvir, simeprevir, encephalopathy improved with unspecified medications. The ribavirin or peginterferon-alfa [dosages and routes not stated]. total duration of treatment was 24 weeks. The causality score Out of these 16 patients, one patient died of multiple organ was 3 (likely treatment related). failure. Case 9: A 67-year-old man, who was diagnosed with HCV- Case 1: A 78-year-old woman, who was diagnosed with infection received treatment with sofosbuvir and ribavirin. HCV-infection, lymphoma and cirrhosis received treatment After 8 weeks of the treatment, he developed anaemia and with sofosbuvir and ribavirin. After 2.9 weeks of the treatment, required hospitalised and blood transfusion. Later, he she developed variceal bleeding and was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Multiple drug

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017

Loading next page...
 
/lp/springer_journal/multiple-drug-hIFKkAS6pI
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39166-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial